Faculty

Main navigation

Latest Alzheimer’s drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...

Read more about Latest Alzheimer’s drug shown less effective in females than males

An open solution to improving research reproducibility

Published: 18 December 2024

Academic and industry scientists collaborate on a new method to characterize research antibodies

Read more about An open solution to improving research reproducibility

Prescribing anti-swelling drug reduces immune response weeks after last dose

Published: 26 February 2025

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy...

Read more about Prescribing anti-swelling drug reduces immune response weeks after last dose

Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro

Published: 25 March 2025

Free, online training program strengthens training and brings specialized care to communities across Quebec...

Read more about Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro

Project to create AI model for ALS receives Génome Québec funding

Published: 17 March 2025

$400,000 will fuel public-private collaboration to discover new disease biomarkers...

Read more about Project to create AI model for ALS receives Génome Québec funding

Achievements of clinicians and scientists recognized with King Charles III Coronation Medals

Published: 14 March 2025

Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation...